| Document |
Document Title |
|
WO/2015/044397A1 |
The invention comprises a compound characterized by a general formula (1), wherein OM is an organometallic compound independently selected from the group of an unsubstituted or substituted metal sandwich compound, an unsubstituted or sub...
|
|
WO/2015/000928A1 |
The invention relates to compounds characterized by a general formula (1), wherein X is a group described by a general formula -Kp-Fr Kq-, wherein - Fl is -C(=0)-,-C(=S)-, with I being 0 or 1, - Kp is a Cp-alkyl with p being 0, 1, 2, 3 o...
|
|
WO/2014/129846A1 |
The present invention relates to organic electroluminescent compounds of formula 1 (see below) wherein X, A, B, C and R4, R5, R6, R7, a, b, c. d. e, l, m, and n are as defined in the description. The invention also relates to organic ele...
|
|
WO/2014/126950A1 |
The tristhiourea tripodal metal complexes are a group of coordination compounds having a transition metal linked by coordinate covalent bods to a chelating agent. The chelating agent has a tris-(6-amino-2-pyridylmethyl)amine (TAPA) backb...
|
|
WO/2014/109814A9 |
Disclosed herein are metal complexes that exhibit multiple radiative decay mechanisms, together with methods for the preparation and use thereof.
|
|
WO/2014/118751A1 |
Manganese-containing compounds, their synthesis, and their use for the deposition of manganese containing films are disclosed. The disclosed manganese-containing compounds have one of the formulae (I) and (II) wherein each of R1, R2, R3 ...
|
|
WO/2014/118750A1 |
Manganese-containing compounds, their synthesis, and their use for the deposition of manganese containing films are disclosed. The disclosed manganese-containing compounds have formula (I), formula (II) wherein each of R1, R2, and R3 is ...
|
|
WO/2014/107722A1 |
Manganese coordination complexes with utility as magnetic resonance probes and as biological reductant sensors are disclosed. In one embodiment, ligands can stabilize both the Mn2+ and Mn3+ oxidation states. In the presence of a reductan...
|
|
WO/2014/045732A1 |
The objective of the present invention is to provide: a new method for producing hydrogen peroxide by direct synthesis that can be substituted for the conventional anthraquinone process; and a catalyst to be used for the method. The pres...
|
|
WO/2013/188554A1 |
The invention provides compositions and methods of using the compositions in fluorinating aryl precursors containing a leaving group replaceable by fluoride ion. The compositions include a metal ion source, a fluoride ion source, and a c...
|
|
WO/2013/188377A1 |
Atomic layer deposition (ALD) and chemical vapor deposition (CVD) precursors that are useful for forming metal-containing films are provided. These compounds include triazapentadienyl -imino enolate compounds and α-imino ketone compound...
|
|
WO/2013/184484A1 |
This invention relates to processes and reagents for making diaryliodonium salts, which are useful for the preparation of fluorinated and radiofluorinated aromatic compounds.
|
|
WO/2013/150486A1 |
The present invention relates to new radiotracers of formula (III): said compounds of formula (III) being obtainable from new complexing agents of formula (II), which can themselves be obtained from new precursors of formula (I), and the...
|
|
WO/2013/082028A1 |
A reagent for carrying out a difluoromethylation reaction of unsaturated compounds and ring-nitrogen-containing aromatic compounds, a zinc difluoro-methanesulfinate, as well as a method for making the reagent and a method for its use are...
|
|
WO/2013/081685A1 |
Methods of halogenating a carbon containing compound having an sp3 C-H bond are provided. Methods of fluorinating a carbon containing compound comprising halogenation with Cl or Br followed by nucleophilic substitution with F are provide...
|
|
WO/2013/071059A1 |
The invention provides for the treatment of disorders related to viral infection, using salen manganese compounds.
|
|
WO/2013/048965A1 |
The present disclosure relates to methods of treating a range of diseases or conditions. The methods involve administration of a superoxide dismutase mimetic
|
|
WO/2013/043767A2 |
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...
|
|
WO/2013/043874A2 |
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation r...
|
|
WO/2013/033864A1 |
The present invention concerns the synthesis of dry powdered manganese complexes using spray-drying or freeze-drying methods.
|
|
WO/2013/032716A1 |
Paste compositions, methods of making a paste composition, photovoltaic cells, and methods of making a photovoltaic cell contact are disclosed. The paste composition can include a conductive metal component such as aluminum, phosphate gl...
|
|
WO/2013/028639A1 |
Methods of halogenating a carbon containing compound having an sp3 C-H bond are provided. Methods of fluorinating a carbon containing compound comprising halogenation with Cl or Br followed by nucleophilic substitution with F are provide...
|
|
WO/2012/172892A1 |
Provided are: a metal salen complex compound which has excellent non-invasive nature and can be efficiently delivered to an affected part; a local anesthetic which contains the metal salen complex compound; and an anti-malignant tumor ag...
|
|
WO/2012/155417A1 |
Disclosed are the molecular sieve-like metal-diimidazole polyporous coordination polymer,preparation method, and use thereof. The present new type of molecular sieve-like metal-diimidazole polyporous coordination polymer has the followin...
|
|
WO/2012/154436A2 |
Embodiments of the present disclosure provide for polynuclear manganese cluster compounds, methods of making, methods of use, method of producing hydrogen and oxygen from water, and the like.
|
|
WO/2012/142087A1 |
Metal bleach catalysts that are complexes of a transition-metal and a dioxo ligand, cleaning compositions comprising such metal bleach catalysts, and methods of using such metal bleach catalysts, are described herein.
|
|
WO/2012/134615A1 |
Pyridyldiamido transition metal complexes are disclosed for use in alkene polymerization.
|
|
WO/2012/134613A2 |
Pyridyldiamido transition metal complexes are disclosed for use in alkene polymerization.
|
|
WO/2012/125439A2 |
Methods and precursors are provided for deposition of elemental manganese films on surfaces using metal coordination complexes comprising an eta-3-bound monoanionic four-electron donor ligands selected from amidinate, mixed ene-amido and...
|
|
WO/2012/122349A1 |
The present invention discloses catalyst compositions employing transition metal complexes with a thiolate ligand. Methods for making these transition metal complexes and for using such compounds in catalyst compositions for the polymeri...
|
|
WO/2012/111380A1 |
The molecular structure of a metal salen complex erxhibiting a pharmacological effect has been clarified, and provided are a metal salen complex provided with such a molecular structure, as well as a derivative of the complex. A metal sa...
|
|
WO/2012/110063A1 |
A process for preparing amino acid chelate compounds, characterized in that metal oxides and/or metal carbonates and/or metal sulfates and/or metal chlorides and/or metal hydroxides are mechanically activated in solid form and then the a...
|
|
WO/2012/106694A2 |
A novel class of lanthanide metal phenoxyimine complexes can be used as an ingredient of a catalyst system. The catalyst system can be used in polymerizations of ethylenically unsaturated hydrocarbon monomers.
|
|
WO/2012/106697A2 |
A novel class of lanthanide metal salen complexes can be used as an ingredient of a catalyst system. The catalyst system can be used in polymerizations of ethylenically unsaturated hydrocarbon monomers.
|
|
WO/2012/106695A2 |
A novel class of aminidate complexes can be used as an ingredient of a catalyst system. The catalyst system can be used in polymerizations of ethylenically unsaturated hydrocarbon monomers.
|
|
WO/2012/099707A2 |
Ul3(1,4-dioxane)1.5 and Ul4(1,4-dioxane)2, were synthesized in high yield by reacting turnings of elemental uranium with iodine dissolved in 1,4-dioxane under mild conditions. These molecular compounds of uranium are thermally stable and...
|
|
WO/2012/060428A1 |
Disclosed is an (amide amino alkane) metal compound represented in general formula 1, and a method of manufacturing the metal-containing thin film using said metal compound. (In the formula, M represents a metal atom, R1 represents a lin...
|
|
WO/2012/048815A1 |
The invention relates to a method for producing metal complexes of formula (2) [MaLxXn]Ym (2), where M is a metal from the group consisting of Mn(ll), Mn(lll), Mn(IV), Fe(ll), Fe(lll) or Fe(IV), X is a coordinating compound selected from...
|
|
WO/2012/017869A1 |
[Problem] To provide a metal complex dye, a photoelectric conversion element and a photoelectrochemical cell with a high conversion efficiency and excellent durability. [Solution] A metal complex dye comprising a ligand LL1 represented b...
|
|
WO/2012/017103A1 |
The invention relates to novel compounds such as succinimidyl ester of the Zn(ll) dithiocarbamate of isonipecotic acid and succinimidyl ester of Zn(ll) of dithiocarbamate of nipecotic acid; to the methods for preparing same, causing any ...
|
|
WO/2011/157716A1 |
The present invention relates to new peptides, pharmaceutical composition and cosmetic composition comprising them and their use for wound healing.
|
|
WO/2011/151399A1 |
The present invention is directed to a rhenium complex of general Formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X is Se; Y is NH, O or S or is a methylene group; Z is halogen; m = 0, 1, or 2 and p = 0, 1, ...
|
|
WO/2011/133115A1 |
The present invention relates to a radiolabelling imaging agent comprising ornithine and derivatives thereof modified to incorporate a Technetium (99n,Tc) radiolabel. The radioiabelled imaging agents are substrates for Ornithine Decarbox...
|
|
WO/2011/110315A1 |
The present invention relates to new rhenium compounds of formula (I) with medical utility, corresponding pharmaceutical compositions as well as medical uses thereof.
|
|
WO/2011/106906A1 |
The present invention concerns synthesising manganese complexes in essentially non-aqueous solutions.
|
|
WO/2011/095307A1 |
The invention relates to a method for producing homogeneous solutions of metal complexes of general formula (2): [MaLxXn]Ym , where M is a metal from the group comprising Mn(II), Mn(III), Mn(IV), Fe(II), Fe(III) or Fe(IV), X is a coordin...
|
|
WO/2011/095308A1 |
The invention describes a process for producing metal complexes of the general formula (2): [MaLxXn]Ym (2), where M is a metal from the group comprising Mn(II), Mn(III), Mn(IV), Fe(II), Fe(III) or Fe(IV), X is a coordinated compound sele...
|
|
WO/2011/075618A1 |
This invention relates to a method for characterizing the pores of reticulated framework structures and using these characteristics to predict the actual performance characteristics of the reticulated framework structures as membranes fo...
|
|
WO/2011/066935A2 |
The invention relates to compounds in solid form, containing a) one or more manganese complex compounds of the general formula (1), where M is independently selected from manganese in the III or IV oxidation state, X is independently a c...
|
|
WO/2011/058277A1 |
The present invention relates to novel spin-transition materials, doped with a fluorescent agent, as well as to a method for preparing same, and to a method for detecting temperature changes by means of said materials.
|
